Cross-fire doses from beta-emitting radionuclides in targeted radiotherapy. A theoretical study based on

S A Enger1, T Hartman, J Carlsson

  • 1Division of Biomedical Radiation Sciences, Department of Oncology, Radiology and Clinical Immunology, Rudbeck Laboratory, Uppsala University, SE-751 85 Uppsala, Sweden. shirin.enger@bms.uu.se